These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 2441681)
1. Biochemical and immunochemical analysis of a breast carcinoma associated antigen defined by the monoclonal antibody NCRC-11. Price MR Arch Geschwulstforsch; 1987; 57(3):177-80. PubMed ID: 2441681 [TBL] [Abstract][Full Text] [Related]
2. Multiple epitopes on a human breast-carcinoma-associated antigen. Price MR; Edwards S; Owainati A; Bullock JE; Ferry B; Robins RA; Baldwin RW Int J Cancer; 1985 Nov; 36(5):567-74. PubMed ID: 2414233 [TBL] [Abstract][Full Text] [Related]
3. Identification of a monoclonal antibody-defined breast carcinoma antigen in body fluids. Price MR; Crocker G; Edwards S; Nagra IS; Robins RA; Williams M; Blamey RW; Swallow DM; Baldwin RW Eur J Cancer Clin Oncol; 1987 Aug; 23(8):1169-76. PubMed ID: 2443362 [TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of a high molecular weight glycoprotein detectable in human milk and breast carcinomas. Sekine H; Ohno T; Kufe DW J Immunol; 1985 Nov; 135(5):3610-5. PubMed ID: 4045199 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer. Edwards DP; Grzyb KT; Dressler LG; Mansel RE; Zava DT; Sledge GW; McGuire WL Cancer Res; 1986 Mar; 46(3):1306-17. PubMed ID: 3510721 [TBL] [Abstract][Full Text] [Related]
6. Epitope analysis of monoclonal antibody NCRC-11 defined antigen isolated from human ovarian and breast carcinomas. Price MR; Edwards S; Powell M; Baldwin RW Br J Cancer; 1986 Sep; 54(3):393-400. PubMed ID: 2428391 [TBL] [Abstract][Full Text] [Related]
7. Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker. Bray KR; Koda JE; Gaur PK Cancer Res; 1987 Nov; 47(22):5853-60. PubMed ID: 2444335 [TBL] [Abstract][Full Text] [Related]
8. Characterization and distribution in normal and tumoral human tissues of breast cancer-associated antigen defined by monoclonal antibody 7B10. Pancino GF; Le Doussal V; Mortada MH; Berthon P; Osinaga E; Calvo F; Roseto A Cancer Res; 1989 Dec; 49(24 Pt 1):7078-85. PubMed ID: 2555058 [TBL] [Abstract][Full Text] [Related]
9. Detection of antigens recognized by a novel monoclonal antibody in tissue and serum from patients with breast cancer. Iacobelli S; ArnĂ² E; D'Orazio A; Coletti G Cancer Res; 1986 Jun; 46(6):3005-10. PubMed ID: 3516389 [TBL] [Abstract][Full Text] [Related]
10. Elevated levels of a high molecular weight antigen detected by antibody W1 in sera from breast cancer patients. Linsley PS; Ochs V; Laska S; Horn D; Ring DB; Frankel AE; Brown JP Cancer Res; 1986 Oct; 46(10):5444-50. PubMed ID: 2428478 [TBL] [Abstract][Full Text] [Related]
11. Expression of ductal carcinoma antigen in breast cancer sera as defined using monoclonal antibody F36/22. Papsidero LD; Nemoto T; Croghan GA; Chu TM Cancer Res; 1984 Oct; 44(10):4653-7. PubMed ID: 6088042 [TBL] [Abstract][Full Text] [Related]
12. Selection of a monoclonal antibody reactive with a high-molecular-weight glycoprotein circulating in the body fluid of gastrointestinal cancer patients. Sakurai Y; Hirohashi S; Shimosato Y; Kodaira S; Abe O Cancer Res; 1988 Jul; 48(14):4053-8. PubMed ID: 2454734 [TBL] [Abstract][Full Text] [Related]
13. A human breast tissue-associated antigen detected by a monoclonal antibody. Thompson CH; Jones SL; Whitehead RH; McKenzie IF J Natl Cancer Inst; 1983 Mar; 70(3):409-19. PubMed ID: 6187962 [TBL] [Abstract][Full Text] [Related]
14. Binding and endocytosis of a monoclonal antibody to a high molecular weight human milk fat globule membrane-associated antigen by cultured MCF-7 breast carcinoma cells. Aboud-Pirak E; Sergent T; Otte-Slachmuylder C; Abarca J; Trouet A; Schneider YJ Cancer Res; 1988 Jun; 48(11):3188-96. PubMed ID: 3365702 [TBL] [Abstract][Full Text] [Related]
15. Expression of tumour-associated antigens in breast cancer primary tissue compared with serum levels. Cannon PM; Ellis IO; Blamey RW; Bell J; Elston CW; Robertson JF Eur J Surg Oncol; 1993 Dec; 19(6):523-7. PubMed ID: 8270037 [TBL] [Abstract][Full Text] [Related]
16. Identification of a cell-surface antigen (LEA.135) associated with favorable prognosis in human breast cancer. Imam SA; Esteban EF; Chen RS; Cardiff RD; Taylor CR Cancer Res; 1993 Jul; 53(14):3233-6. PubMed ID: 7686814 [TBL] [Abstract][Full Text] [Related]
17. A novel monoclonal antibody (7B10) with differential reactivity between human mammary carcinoma and normal breast. Pancino G; Charpin C; Calvo F; Guillemin MC; Roseto A Cancer Res; 1987 Aug; 47(16):4444-52. PubMed ID: 3607774 [TBL] [Abstract][Full Text] [Related]
18. Survival in breast cancer related to tumour oestrogen receptor status and immunohistochemical staining for NCRC 11. Angus B; Napier J; Purvis J; Ellis IO; Hawkins RA; Carpenter F; Horne CH J Pathol; 1986 Aug; 149(4):301-6. PubMed ID: 3020217 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical reactivity of anti-melanoma monoclonal antibody 225.28S in human breast cancer biopsies. Dell'Erba L; Calo-Gabrieli G; Caruso ML; Thomas R; Cortino G; Valentini AM; Muto P; Albrizio M; Pastena MI; Lastoria S Anticancer Res; 2001; 21(2A):925-30. PubMed ID: 11396186 [TBL] [Abstract][Full Text] [Related]
20. Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas. Friedman EL; Hayes DF; Kufe DW Cancer Res; 1986 Oct; 46(10):5189-94. PubMed ID: 3530435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]